Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients

dc.creator	McCulloch, R
dc.creator	Lewis, D
dc.creator	Crosbie, N
dc.creator	Eyre, TA
dc.creator	Bolam, S
dc.creator	Arasaretnam, A
dc.creator	Creasey, T
dc.creator	Goradia, H
dc.creator	McMillan, A
dc.creator	Dawi, S
dc.creator	Harrison, S
dc.creator	Miles, O
dc.creator	Robinson, A
dc.creator	Dutton, D
dc.creator	Wilson, MR
dc.creator	McKay, P
dc.creator	Follows, G
dc.creator	Phillips, N
dc.creator	Patmore, R
dc.creator	Lambert, J
dc.creator	Bishton, M
dc.creator	Osborne, W
dc.creator	Johnston, R
dc.creator	Kirkwood, AA
dc.creator	Rule, S
dc.date	2022-03-07T11:37:03Z
dc.date	2021-04
dc.date.accessioned	2022-05-26T21:09:34Z
dc.date.available	2022-05-26T21:09:34Z
dc.identifier	0007-1048
dc.identifier	http://hdl.handle.net/10026.1/18902
dc.identifier	10.1111/bjh.17363
dc.identifier	1365-2141
dc.identifier.uri	http://localhost:8080/xmlui/handle/CUHPOERS/228948
dc.format	290 - 298
dc.language	en
dc.language	en
dc.publisher	Wiley
dc.relation	ISSN:0007-1048
dc.relation	E-ISSN:1365-2141
dc.rights	2022-03-08
dc.rights	Not known
dc.title	Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients
dc.type	Journal Article

Files in this item

Files	Size	Format	View
Br J Haematol - ... ted Kingdom real‐world.pdf	381.5Kb	application/pdf	View/Open